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Nephropathy develops in many but not all patients with long-
standing type 1 diabetes. Substantial efforts to identify genotypic
differences explaining this differential susceptibility have been
made, with limited success. Here, we show that the expression of
the transforming growth factor β1 gene (Tgfb1) affects the devel-
opment of diabetic nephropathy in mice. To do this we genetically
varied Tgfb1 expression in five steps, 10%, 60%, 100%, 150%, and
300% of normal, in mice with type 1 diabetes caused by the Akita
mutation in the insulin gene (Ins2Akita). Although plasma glucose
levels were not affected by Tgfb1 genotype, many features of
diabetic nephropathy (mesangial expansion, elevated plasma cre-
atinine and urea, decreased creatinine clearance and albuminuria)
were progressively ameliorated as Tgfb1 expression decreased
and were progressively exacerbated when expression was in-
creased. The diabetic 10% hypomorphs had comparable creatinine
clearance and albumin excretion to wild-type mice and no harmful
changes in renal morphology. The diabetic 300% hypermorphs
had ∼1/3 the creatinine clearance of wild-type mice, >20× their
albumin excretion, ∼3× thicker glomerular basement membranes
and severe podocyte effacement, matching human diabetic ne-
phropathy. Switching Tgfb1 expression from low to high in the
tubules of the hypomorphs increased their albumin excretion
more than 10-fold but creatinine clearance remained high. Switch-
ing Tgfb1 expression from low to high in the podocytes markedly
decreased creatinine clearance, but minimally increased albumin
excretion. Decreasing expression of Tgfb1 could be a promising
option for preventing loss of renal function in diabetes.
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Diabetes is the number one cause of end-stage renal diseasein the United States and many other developed countries.
However, despite having similar levels of blood glucose only
20–40% of all diabetic patients develop diabetic nephropathy.
In diabetic nephropathy, increased expression of transforming
growth factor β1 (TGFβ1) has been demonstrated to promote
accumulation of extracellular matrix components (1), apoptosis
(2), dedifferentiation of podocytes (3), and epithelial–mesenchymal
transition of proximal tubules (4), all of which are thought to fa-
cilitate a decline in nephron number and renal function.
Tgfb1-null mice on a mixed genetic background show severe
multiorgan inflammation with massive infiltration of lympho-
cytes and macrophages that culminates in death by 3–4 wk of age
(5, 6). Their death effectively prevents determining whether
absence of TGFβ1 influences the development of nephropathy.
To overcome this problem and also to allow the study of the
effects of above-normal TGFβ1, we have generated mice with
five genetically graded levels of TGFβ1, and have made them
diabetic with the Ins2Akita mutation, which causes pancreatic
beta-cell dysfunction and type 1 diabetes.
Here we show that the features characteristic of diabetic ne-
phropathy are progressively minimized as Tgfb1 expression is
decreased below normal and are progressively exacerbated when
expression is increased above normal.
Generation of Akita Diabetic Mice Having Five Genetically
Different Levels of Tgfb1 Expression
We recently described the generation of C57BL/6 mice having
a low-expressing Tgfb1 allele (Tgfb1L), which can be switched to
high expressing form (Tgfb1H) by exposure to Cre recombinase,
and the combination of these low and high expressing alleles
with the wild-type allele (Tgfb1+) to produce mice having
Tgfb1 mRNA expression graded in five steps from 10% to 300%
normal (7). We have now crossbred these mice with mice having
the Akita mutation in the Ins2 gene (8) to generate type 1 diabetic
mice with different TGFβ1 levels. Male C57BL/6 Akita diabetic
mice with the following five genotypes were studied: Tgfb1L/L:
Ins2Akita/+ (hereafter called L/L:A/+), Tgfb1L/+:Ins2Akita/+ (L/+:A/+),
Tgfb1+/+:Ins2Akita/+ (WT:A/+), Tgfb1H/+:Ins2Akita/+ (H/+:A/+),
and Tgfb1H/H:Ins2Akita/+ (H/H:A/+).
Fig. 1A shows that Akita diabetic mice with the five Tgfb1
genotypes have a graded expression of Tgfb1 mRNA in their
kidneys, and that their plasma TGFβ1 levels have a similar
gradation (Fig. 1B). They all have about three times the plasma
concentration of glucose and about one third the plasma insulin
concentration of wild-type nondiabetic C57BL/6 mice, indicative
of type 1 diabetes. These plasma glucose and plasma insulin
concentrations were not significantly affected by the Tgfb1 ge-
notype (Fig. 1 C and D and SI Appendix, Fig. S8).
General Characteristics of Akita Diabetic Mice with Five
Graded Expressions of Tgfb1
The body weights of the L/L:A/+ Akita diabetic mice were about
15% less than those of the Akita mice with the other Tgfb1 ge-
notypes (SI Appendix, Table S1), a result similar to our previous
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finding with nondiabetic L/L mice (7). The heart weights of the
L/L:A/+ and H/H:A/+ mice were, respectively, ∼10% and 20%
lower than that of the mice with the other Tgfb1 genotypes, but
heart weight/body weight ratios did not differ significantly among
all five genotypes (SI Appendix, Table S1). Heart rates were not
significantly different (SI Appendix, Fig. S1). The kidney weight/
body weight ratio was ∼15% lower in the L/L:A/+ mice and
∼30% higher in the H/H:A/+ mice in comparison with Akita
diabetic mice with wild-type Tgfb1 expression (SI Appendix, Ta-
ble S1). Plasma cholesterol and plasma triglyceride concentra-
tions were not affected by the Tgfb1 genotypes.
Effects of Tgfb1 on Urinary Excretion of Albumin, Water, and
Glucose
Because nephropathy/renal failure in human patients is associ-
ated with long-term diabetes, the effects of graded expression of
Tgfb1 were studied in mature adult 40-wk-old C57BL/6 Akita
diabetic mice. Using metabolic cages, we found that the L/L:A/+
diabetic mice, like the nondiabetic L/L mice, excreted very little
amount of albumin (Fig. 1E and SI Appendix, Fig. S2). However,
higher levels of TGFβ1 led to progressive increases in urinary
albumin excretion (Fig. 1E), ranging from microalbuminuria in
the L/+:A/+ diabetic mice (∼80 μg/day) to macroalbuminuria in
the H/H:A/+ diabetic mice (∼200 μg/day). The urine volumes
of the L/L:A/+ Akita diabetic mice (Fig. 1F) were much reduced
compared with the polyuric urine volumes of the other Akita
diabetic mice (∼1 mL/day versus ∼30 mL/day). In addition to not
having polyuria, the L/L Akita mice did not have glucosuria (Fig.
1G), even though they had about three times normal plasma
glucose concentration and about one third normal plasma insulin
concentration (Fig. 1 C and D). Nondiabetic L/L mice also ex-
creted very little amount of glucose (SI Appendix, Fig. S11). The
L/L:A/+ mice had systolic blood pressures ∼20 mmHg above
normal (Fig. 1H). These unusual features are seen in nondiabetic
L/L mice, caused by their having ∼2× normal plasma aldosterone
concentrations (7). Our L/L:A/+ diabetic hypomorphs also have
plasma aldosterone concentrations about twice that of diabetic
mice that are wild type at the Tgfb1 locus (SI Appendix, Fig. S6).
Thus, although the 10% hypomorphs developed additional fea-
tures associated with their hyperaldosteronism, we conclude that
higher-than-normal expression of Tgfb1 in the Akita diabetic mice
caused increased albumin excretion, whereas lower than normal
expression decreased the albuminuria.
Effects of Tgfb1 on Expression of Genes Affecting Renal
Function
To uncover factors affecting the nephropathy in our diabetic
mice with graded expression of Tgfb1, we determined the ex-
pression in the kidney of mRNAs coding for proteins involved in
renal function and albumin excretion (Fig. 1 I–M). Nephrin
(mouse gene: Nphs1) and podocin (Nphs2) were chosen because
they are expressed in renal podocytes and have mutations that
cause congenital nephrotic syndromes in humans (9–12). Megalin
(Lrp2) and cubilin (Cubn), both expressed in the brush border
of renal proximal tubules, were chosen because of their known
contribution to the endocytosis of low molecular weight proteins
and albumin (13–17). Neonatal Fc receptor (Fcgrt) was included
because it is also expressed in the brush border but its primary
effects are on the urinary excretion of immunoglobulins rather
than of albumin (18, 19). The results show that genetic increases
in the expression of Tgfb1 in the Akita diabetic mice caused
progressive decreases in the renal expression of nephrin and of
megalin, ranging from ∼250% normal in the L/L:A/+ mice to
∼50% normal in the H/H:A/+ mice. Expression of cubilin and
of the neonatal Fc receptor was unaffected. We conclude that
progressive increases in Tgfb1 expression from 10% to 300%
normal are accompanied by progressive decreases in nephrin
and megalin expression from ∼250% to ∼50% normal but
without changes in the expression of podocin, cubulin, and the
neonatal Fc receptor.
Excretory Function of Nondiabetic and Akita Diabetic Mice
with Graded Tgfb1 Expression
The effects of graded expression of Tgfb1 on renal function were
studied in mature adult 40-wk-old Akita diabetic mice and their
nondiabetic counterparts. The results show that in the non-
diabetic mice changes in Tgfb1 expression had no significant
effects on glomerular filtration rate (GFR) as judged by plasma
levels of urea nitrogen and creatinine, and creatinine clearance
(SI Appendix, Figs. S3–S5). However, in the Akita diabetic mice
we found a highly significant inverse gradation in GFR as Tgfb1
expression varied (Fig. 2 A–C). Thus, GFR was greater than in
Fig. 1. Characterization at age 40 wk
of Akita diabetic mice having five ge-
netically determined levels of Tgfb1
expression. (A) Tgfb1 mRNA in the
kidney. (B) Plasma concentration of
TGFβ1. (C) Plasma glucose concentra-
tion. (D) Plasma insulin concentration.
(E) Urinary albumin excretion. (F) Urine
Volume. (G) Urine glucose excretion.
(H) Systolic blood pressure. (I) Renal
mRNA expression of Nephrin. (J) Podo-
cin. (K) Megalin. (L) Cubilin. (M) Neo-
natal Fc receptor (FcRn). All of the
mice were Akita diabetic. Bars are
color coded to indicate Tgfb1 and
Ins2 genotypes: blue (L/L:A/+), green
(L/+:A/+), white (WT:A/+), yellow
(H/+:A/+), red (H/H:A/+). *P < 0.05,
**P < 0.01 vs. WT:A/+.
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the 10% hypomorphs (L/L:A/+) than in diabetic mice wild type
at the Tgfb1 locus (WT:A/+), but was less in the hypermorphs
(H/+:A/+ and H/H:A/+) than in the WT:A/+ mice. We conclude
that GFR decreases in Akita diabetic mice as the expression of
Tgfb1 increases. In statistical confirmation of this inverse re-
lationship, nonparametric regression analyses showed that Tgfb1
mRNA expression, plasma urea nitrogen, plasma creatinine, and
creatinine clearance (Figs. 1A and 2 A–C) were all strongly re-
lated to the Tgfb1 genotypes (R2 ≥ 0.57 for all four variables).
Two-way ANOVA showed that the interaction of Tgfb1 and
Akita genotype on renal function was highly significant (P <
0.0001). We found one factor that probably contributes to this
interaction; namely, the plasma level of TGFβ1 in the five ge-
notypes (Fig. 1B) proved to be generally about 50% higher in the
40-wk-old diabetic mice than in their nondiabetic counterparts at
12 wk age (7), as it is in human patients (1). We conclude that
the GFR of the diabetic mice is highly dependent on the level
of expression of Tgfb1, ranging from approximately twice
normal in the L/L:A/+ mice to approximately half normal in
the H/H:A/+ mice.
Renal Morphology in Nondiabetic and Akita Diabetic Mice
with Graded Tgfb1 Expression
To uncover the causes of the progressive changes in GFR in our
diabetic mice, we evaluated the microscopic and ultramicro-
scopic status of their glomeruli (Fig. 2 D–R). The microscopic
studies showed that the Akita mice with wild-type Tgfb1 alleles
(WT:A/+) at age 40 wk had pathological changes in their glo-
meruli typical of diabetic nephropathy, including mesangial cell
expansion, less open capillaries and accumulation of periodic
acid-Schiff (PAS)-positive materials (Fig. 2F). These pathologi-
cal changes were completely absent in the Akita mice with the
lowest expression of Tgfb1 (L/L:A/+; Fig. 2D), were still reduced
in the L/+:A/+ mice (Fig. 2E) relative to those in the diabetic
mice with wild-type Tgfb1 (Fig. 2F), but were progressively ex-
acerbated as expression of Tgfb1 increased above normal in the
H/+:A/+ and H/H:A/+ Akita diabetic mice (Fig. 2 G and H).
Fig. 2. Renal excretory function, glo-
merular histology and ultrastructure at
40 wk of age in Akita mice with five
levels of Tgfb1 expression. (A) Plasma
urea nitrogen concentration. (B) Plasma
creatinine concentration. (C) Creatinine
clearance. (D–H) Glomerular histology;
periodic acid-Schiff (PAS) staining with
hematoxylin. (Color-coded scale bar:
50 μm) (D) L/L:A/+. (E) L/+:A/+. (F) WT:A/+.
(G) H/+:A/+. (H) H/H:A/+. (I–M) Glomeru-
lar basement membrane ultra-structure;
color-coded scale bar = 1 μm. (I) L/L:A/+.
(J) L/+:A/+. (K ) WT:A/+. (L) H/+:A/+.
(M ) H/H:A/+. (N–R) Peri-tubular base-
ment membrane ultra-structure; color-
coded scale bar = 1 μm. (N ) L/L:A/+.
(O) L/+:A/+. (P) WT:A/+. (Q) H/+:A/+.
(R) H/H:A/+. (S–V ) Renal phenotypes
in nondiabetic and diabetic mice of
the five Tgfb1 genotypes. (S) Fraction
of PAS-positive mesangial material per
total glomerular tuft cross-sectional area.
(T) Fraction of open capillary area per
total glomerular tuft cross-sectional area.
(U) Thickness of glomerular basement
membrane (GBM). (V) Thickness of tubu-
lar basement membrane (TBM) in the
proximal tubule. Bars and images are
color coded as indicated. Dotted lines in-
dicate nondiabetic WT levels. *P < 0.05,
**P < 0.01 vs. WT:A/+.











The glomeruli of the H/H:A/+ diabetic mice showed essentially
all of the pathological features that are observed in humans with
advanced diabetic nephropathy, including glomerulosclerosis as
indicated by glomerular morphology, accumulation of extracel-
lular matrix, mesangial expansion, and nodular lesions (SI Ap-
pendix, Fig. S7P).
The pathology revealed by light microscopy was further eval-
uated by electron microscopy (Figs. 2 I–M and SI Appendix, Fig.
S7 A–J). The results confirmed that the Akita mice with wild-
type Tgfb1 alleles (WT:A/+) at age 40 wk had ultrastructural
changes typical of advanced diabetic nephropathy, including a
several-fold increase in the thickness of the glomerular basement
membrane (GBM) together with marked podocyte effacement
(Fig. 2K). Both were progressively exacerbated in the H/+:A/+
and H/H:A/+ mice with above normal expression of Tgfb1 (Fig. 2
L, M, and U and SI Appendix, Fig. S7O). The glomerular ultra-
structural pathology was substantially corrected when Tgfb1 ex-
pression was about half normal in the L/+:A/+ mice (Fig. 2 I and
U and SI Appendix, Fig. S7O), and the ultrastructure of the
glomeruli in the L/L:A/+ mice was indistinguishable from that in
wild-type nondiabetic C57BL/6 mouse except that the thickness
of the GBM was about half normal (Fig. 2 I and U and SI Ap-
pendix, Fig. S7O). Podocyte effacement was present in the glo-
meruli of all of the diabetic mice except the L/L:A/+ mice with
one tenth normal Tgfb1 expression. We did not observe any
obvious lesions in the renal vasculature other than in the
glomeruli of the Akita mice. We conclude that the nephrop-
athy observed in the mature Akita mice with type 1 diabetes is
strongly affected by the expression of Tgfb1, ranging from
almost the same as in nondiabetic Tgfb1 wild-type mice (in the
10% hypomorphs) to severe diabetic nephropathy (in the
300% hypermorphs).
The thickness of the tubular basement membrane (TBM)
changed with Tgfb1 expression in the same manner as the
thickness of the GBM, although somewhat less dramatically
(Fig. 2 N–R).
We quantitated the renal pathology in the five Tgfb1 geno-
types by measuring the fraction of PAS-positive area per glo-
merular tuft area, an indicator of mesangial expansion, and
found that PAS-positive material increased more than 10-fold in
the Akita diabetic animals as Tgfb1 expression increased (Fig.
2S), but increased only slightly in the nondiabetic mice (SI Ap-
pendix, Fig. S7K). The open capillary area in the L/L:A/+ hy-
pomorphs decreased from almost twice that in the WT:A/+
diabetic mice to less than one third in the H/H:A/+ diabetic mice
(Fig. 2T), but was not significantly affected by Tgfb1 expression
in the nondiabetic mice (SI Appendix, Fig. S7L). The thicknesses
of the GBM and TBM in the diabetic mice were affected in
remarkably similar ways by the changes in Tgfb1 expression (Fig.
2 U and V), but were not significantly affected in the nondiabetic
mice (SI Appendix, Fig. S7 M and N). Thus, the quantitative
evaluation of the light and electron microscope images of the
glomeruli confirm the conclusions drawn from their visual in-
spection, namely that below normal Tgfb1 expression ameliorates
the nephropathy caused by diabetes, whereas above-normal ex-
pression exacerbates it.
Effects of Podocyte-Specific or Proximal Tubule-Specific
Switching of Tgfb1 from Low to High in the L/L:A/+
Diabetic Mice
To determine whether the increased urinary albumin and de-
creased renal function occurring in the L/L Akita mice is due to
changes in the podocytes, we generated L/L:A/+ P mice having a
Cre transgene driven by the promoter of the podocin gene
(Nphs2), which is active only in podocytes. Likewise, we gener-
ated L/L:A/+ T mice having a Cre transgene driven by the
promoter of the gamma-glutamyl transferase 1 gene (Ggt1),
which is active only in the brush border of Tubule cells. The
podocin-Cre switches Tgfb1 gene expression from low to high in
podocytes during development and life-long thereafter. The
tubule-specific Ggt1-Cre is inducible by tamoxifen and
switches Tgfb1 expression from low to high in proximal tubule
cells after mice are treated with tamoxifen.
Switching Tgfb1 expression from low to high in either the tubules
or the glomeruli of the L/L:A/+ mice had no effect on the hyper-
glycemia caused by the Akita mutation (SI Appendix, Fig. S8).
However, the blood pressure of the L/L:A/+ T diabetic mice in
which Cre recombination had been induced in the tubules was
decreased by ∼10 mmHg (from ∼130 mmHg to ∼120 mmHg;
SI Appendix, Fig. S9), and the decreased urine volume of the L/L:A/+
mice was increased (from ∼1.1 mL/day to ∼2.5 mL/day; Fig. 3B),
indicating that the abnormally high blood pressure and abnor-
mally low urine volumes of the L/L:A/+ mice are at last partly
due to low expression of Tgfb1 in the tubules.
Switching Tgfb1 expression from low to high in the glomeruli
prevented the development in the L/L:A/+ mice of the lower
than normal plasma urea nitrogen and plasma creatinine and
higher creatinine clearance indicative of increased GFR (pink
bars in Fig. 3 D–F). Switching in tubules had no effect on the
GFR (turquoise bars in Fig. 3 D–F). Urinary excretion of albu-
min and glucose was markedly affected by switching Tgfb1 ex-
pression from low to high in the tubules (turquoise bar in Fig. 3 A
and C), but only slightly by glomerulus-specific switching (pink
bar in Fig. 3 A and C). We conclude that GFR is affected by
Tgfb1 expression in the glomerulus, whereas albumin and glucose
excretion is affected by Tgfb1 expression in the tubule.
Changes in the renal pathology of the L/L:A/+ Akita mice
after switching Tgfb1 expression from low to high in podocytes or
tubules were in line with the changes in GFR and albumin ex-
cretion. Thus, the glomeruli of the L/L:A/+ diabetic mice
appeared normal except for a slightly above normal open cap-
illary area, but switching Tgfb1 expression from low to high in
their podocytes damaged them and they became the same as in
the WT:A/+ mice (Fig. 3 G, I, and K–L). In contrast, switching
expression of Tgfb1 in the tubules of the L/L:A/+ T mice left the
glomeruli unchanged, but fibrosis in the tubulointerstitium was
markedly enhanced (Fig. 3 H, J, and K–L). We conclude that
Tgfb1 expression in the glomerulus controls the glomerulo-
sclerosis, whereas Tgfb1 expression in the tubule controls
tubulointerstitial fibrosis.
Transmission electron microscopy showed that the podocyte-
specific switching of Tgfb1 expression in the L/L:A/+ P mice
prevented the development of the abnormally thin GBM that
occurs in the L/L:A/+ mice, but had little effects on the thickness
of the TBM (Fig. 3 M–O and SI Appendix, Fig. S10 A and C). In
contrast, tubule-specific switching from low to high had no ef-
fects on the thickness of the GBM, but the thickness of TBM was
much increased (Fig. 3 M–O and SI Appendix, Fig. S10 B and D).
We conclude that Tgfb1 expression in the glomerulus controls
the thickness of the GBM, whereas Tgfb1 expression in the tu-
bule controls the thickness of the TBM.
Discussion
The most life-threatening component of diabetic nephropathy is
the decrease in GFR, which develops in many type 1 diabetic
patients as a result of mesangial expansion and the accumulation
of extracellular matrix in the glomerulus (glomerulosclerosis)
together with increased GBM thickness, podocyte foot process
retraction/effacement, and tubulointerstitial fibrosis. We have
shown here that all these features are present in mature Akita
type 1 diabetic mice, which have increased expression of Tgfb1 as
a result of genetic changes. Thus, their GFR is decreased to
about half normal and the pathognomonic features of diabetic
nephropathy are present in their kidneys.
The H/H:A/+ mice with three times normal expression of
Tgfb1 exhibit better than any previous mouse model the features
typically seen in patients with long-term type 1 diabetes. How-
ever, none of these features is present in L/L:A/+ Akita diabetic
mice with one tenth normal expression of Tgfb1. Indeed,
the GFR in the L/L:A/+mice is greater than normal, the GBM is
thinner than normal, and they have less than normal PAS-positive
material in their glomeruli. When Tgfb1 expression was changed
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less dramatically from 150% normal in the H/+:A/+mice to 60%
normal in the L/+:A/+ mice, we found that the GFR still in-
creased and renal morphological abnormalities still decreased in
a graded fashion. Thus, above normal Tgfb1 expression exacer-
bates and below normal expression ameliorates the diabetic
nephropathy that develops in Akita diabetic mice.
The progressive inverse changes in the renal expression of the
mRNAs of nephrin and megalin, but not of podocin, cubilin, and
neonatal Fc receptor, that occurred as Tgfb1 expression was
altered are striking, but of uncertain importance. The 3/4 and 1/2
normal expression of nephrin and megalin in the H/+:A/+ and
H/H:A/+ diabetic mice are likely to be phenotypically un-
important, because heterozygous null mice for these genes
have 1/2 normal expression and no overt phenotypes. However,
whether the Tgfb1-dependent two- to threefold increases of
nephrin and megalin expression in the L/+:A/+ and L/L:A/+
mice contribute to the diabetic phenotypes is uncertain, and
must await further studies, as must deciphering why only two of
these five genes are affected even though all are known to be
involved in albumin excretion.
It is important to note that the L/L:A/+ Akita diabetic mice
did not exhibit the polyuria characteristic of diabetes. Nor did
they have glucosuria, even though they had about three times
normal plasma glucose concentration and about 1/3 normal
plasma insulin concentration. Additionally, they had systolic
blood pressures ∼20 mmHg above normal. The absence of
polyuria and the increased blood pressure were expected be-
cause comparable changes occur in their nondiabetic counter-
parts (7). We did not anticipate the absence of glucosuria,
but the joint absence of polyuria and glucosuria is understand-
able in light of the demonstration (20) that more than 200 water
molecules are coupled to each sugar molecule cotransported by
Na+/glucose cotransporters, which are highly expressed in the
proximal tubule. Support for this inference is provided by our
finding that the absence of polyuria and glucosuria and the in-
creased blood pressure were all partly corrected in the diabetic
mice with Tgfb1 expression switched from low to high specifically
in tubules.
By switching Tgfb1 expression in the 10% hypomorphs from
low to high specifically in podocytes, we showed that the GFR is
affected by Tgfb1 expression in the glomerulus, as would be
expected given the changes that increased Tgfb1 expression
causes in the morphology of the glomerulus. Switching in tubules
did not alter the GFR.
Our experiments show that albumin excretion in the Akita
diabetic mice is greatly affected by Tgfb1 expression. Thus, it is
comparable to nondiabetic wild type in the 10% hypomorphs,
but increases from microalbuminuria to macroalbuminuria as Tgfb1
expression increases from 1/2 to ∼3 times normal. Whether the
proteinuria in diabetic nephropathy is due to podocyte/glomerular
dysfunction and/or to tubule dysfunction is a subject of debate (21–
24). We found that the albuminuria of the 10% hypomorphs was
increased 20 fold by switching Tgfb1 expression from low to high
in the tubules, but only fourfold by switching in the podocytes.
Consequently, our results favor the view that the albuminuria
that develops in type 1 diabetic mice is mainly due to decreased
tubular reabsorption/degradation rather than to increased glo-
merular filtration.
The absence of nephropathy in the diabetic 10% hypomorphs
indicates that substantially decreasing Tgfb1 expression in di-
abetics could have therapeutic benefits. Unfortunately, the 10%
hypomorphs develop aldosteronism as a result of the very low
Tgfb1 expression in the adrenal gland (7). Consequently, lowering
expression to this degree throughout the body is contraindicated.
Fig. 3. Renal function and histology at age 40 wk in L/L Akita diabetic mice with Tgfb1 switched from low to high by podocyte-specific or proximal tubule-
specific induction of Cre recombinase. (A) Urinary albumin excretion. (B) Urine volume. (C) Urine glucose excretion. (D) Plasma urea nitrogen concentration.
(E) Plasma creatinine concentration. (F) Creatinine clearance. (G and H) Periodic acid-Schiff (PAS) staining with hematoxylin of the glomerulus. (Scale bar:
50 μm.) (G) L/L:A/+ mice with podocyte-specific switching (L/L:A/+ P). (H) L/L:A/+ mice with proximal tubule-specific switching (L/L:A/+ T). (I and J) Masson’s
trichrome staining of renal cortex. (I) L/L:A/+ P. (J) L/L:A/+ T. (K) Percentage area of PAS-positive mesangial material per glomerular tuft. (L) Percentage of
open capillary area per glomerular tuft. (M) Thickness of glomerular basement membrane (GBM). (N) Width of podocyte foot processes. (O) Thickness of
tubular basement membrane (TBM) in proximal tubules. Bars are color coded to indicate switching: blue (L/L:A/+; no switching), pink (L/L:A/+ P, in podocytes),
and turquoise (L/L:A/+ T, in tubules). *P < 0.05, **P < 0.01 vs. L/L:A/+ mice.











Nevertheless, our results indicate that this problem might be
avoided, while still retaining efficacy, if the reduction of Tgfb1
expression was only in the kidney.
In summary, we have studied the renal phenotype of mature
Akita diabetic male mice having five genetically controlled levels
of TGFβ1 and have demonstrated that below normal Tgfb1 ex-
pression ameliorates the decreased GFR and nephropathy that
result from long-standing type 1 diabetes, whereas above normal
Tgfb1 expression exacerbates these abnormalities. We have also
shown that reducing Tgfb1 expression in the glomerulus is more
important in avoiding the decrease in GFR than altering ex-
pression in the tubule, whereas expression in the tubule is more
important in controlling interstitial fibrosis and albuminuria.
Suppressing TGFβ1 action in the kidney as a whole, or specifi-
cally in podocytes, could be a promising option for treating/
preventing the progressive deterioration of renal function that
leads to end-stage renal disease in many diabetic patients.
Materials and Methods
Animals. To study the effects of TGFβ1 on the phenotype in diabetes, we
crossbred heterozygous and homozygous mice having hypomorphic (L) or
hypermorphic (H) alleles for TGFβ1 on a C57BL/6 genetic background (7) with
mice having heterozygous Akita mutation in the insulin 2 gene, which is an
animal model of type 1 diabetes mellitus (Akita mice), on a C57BL/6 genetic
background (The Jackson Laboratory) (8). Because the L allele can be con-
verted into the H allele by Cre-loxP recombination, we used this property
to generate mice with tissue-specific overexpression of TGFβ1 in the hypo-
morphs. To study the effects of proximal tubule-specific overexpression
on the phenotype in the L/L Akita mice, we used the Ggt1 promoter-
driven Cre transgene (Ggt1-cre/ERT2; European Mouse Mutant Archive)
(25), which is induced by tamoxifen injection (50 mg/kg/day IP in sesame oil for
5 d) at age 4wk. To study the effects of podocyte-specific overexpression on the
phenotype in the L/L Akita mice, we used the podocin (Nphs2) promoter-
driven Cre transgene (Nphs2-cre; The Jackson Laboratory) (26). All mice were
kept under the husbandry conditions in conformance with guidelines of
University of North Carolina Institutional Animal Care and Use Committee.
Measurement of Biological Parameters. Plasma glucose levels were deter-
mined with the glucose oxidase method (Wako Chemical). Plasma insulin
levels were determined with ELISA (Crystal Chem). Plasma urea nitrogen
concentrations and plasma and urine electrolytes were determined with the
Vitros 250 Chemistry system (Ortho-Clinical Diagnostics). Plasma total cho-
lesterol (Wako) and triglyceride (Stanbio Laboratory) were measured with
enzymatic colorimetric methods. Plasma creatinine levels were studied with
liquid chromatography tandem mass spectrometry (LC-MS/MS) as described
(27). Plasma TGFβ1 and aldosterone were studied with ELISA (Quantikine
Mouse/Rat/Porcine/Canine TGFβ1 Immunoassay, R&D Systems; Aldosterone
EIA kit, Enzo Life Sciences). Metabolic balance studies were performed using
metabolic cages (Solo Mouse Metabolic Cage; Tecniplast).
Histology. After the inferior vena cava is cut, the left ventricle was punctured
by a 23-gauge needle and perfused with PBS for 3 min and with 4% para-
formaldehyde for 5 min. Thereafter, the tissues were dissected out and put in
4% paraformaldehyde at least 3 d. These were then paraffin embedded and
sectioned. The stained sections were prepared by Center for Gastrointestinal
Biology and Diseases Histology Core and imaged on an Olympus BX61
microscope. For electron microscopy, grids were prepared by Microscopy
Services Laboratory and imaged on a Zeiss TEM 910 transmission electron
microscope.
Blood Pressure and Pulse Rate Measurement. We measured blood pressure
and pulse rate with the tail-cuff method (28).
Quantitative Reverse Transcription-PCR. Total RNA was extracted from dif-
ferent tissues and the mRNAs were assayed by quantitative reverse tran-
scription-PCR as described (29). The primers and the probes used to measure
the mRNAs are shown in SI Appendix, Table S2.
Statistical Analysis. Data are expressed as means ± SEs. To compare groups,
we used one-factor or two-factor ANOVA. Post hoc pairwise comparisons
were performed by Tukey–Kramer Honestly Significance Differences test
(JMP 9.0; SAS Institute).
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